Atlas Trials

Open-Label, Pilot Study of TG100801 in Patients With Choroidal Neovascularization Due to AMD

Clinical trial NCT00509548 · TERMINATED

Trial details

NCT number
NCT00509548
Sponsor
TargeGen
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Macular DegenerationChoroidal Neovascularization
Start date
2007-07-01
Primary completion
2008-03-01
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.